Ticker Details
Vaxcyte, Inc.
IPO Date:	July 12, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$8.4B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.02 | 2.51%
Avg Daily Range (30 D):	$1.39 | 2.66%
Avg Daily Range (90 D):	$1.02 | 2.13%

Institutional Daily Volume
Avg Daily Volume:	.64M
Avg Daily Volume (30 D):	1.1M
Avg Daily Volume (90 D):	1.15M

Trade Size
Avg Trade Size (Sh.):	60
Avg Trade Size (Sh.) (30 D):	58
Avg Trade Size (Sh.) (90 D):	58

Institutional Trades
Total Institutional Trades:	3,980
Avg Institutional Trade:	$3.69M
Avg Institutional Trade (30 D):	$4.52M
Avg Institutional Trade (90 D):	$3.41M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$7.61M
Avg Closing Trade (30 D):	$13.48M
Avg Closing Trade (90 D):	$9.74M
Avg Closing Volume:	145.68K

News

Feb 2, 2026 @ 9:05 PM Vaxcyte Announces Closing of $632.5 Million Public... Source: Globe Newswire

Jan 30, 2026 @ 4:33 AM Vaxcyte Announces Pricing of $550 Million Public O... Source: Na

Jan 22, 2026 @ 10:00 PM Vaxcyte Advances Adult and Infant Programs for VAX... Source: Vaxcyte, Inc.

Sep 30, 2025 @ 3:42 PM Thermo Fisher Launches Four-Part Bond Offering Ahe... Source: Vandana Singh

Aug 21, 2025 @ 5:00 PM Pneumococcal Infections Clinical Trial Analysis: K... Source: Delveinsight

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-4.84	$-1.56	$-1.22
Diluted EPS	$-4.84	$-1.56	$-1.22
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-657.2M	$-212.83M	$-166.57M
Operating Income / Loss	$-811.56M	$-242.38M	$-226.22M
Cost of Revenue
Net Cash Flow	$-768.96M	$-25.52M	$-40.11M
PE Ratio